Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters. | Pharmaceutics | 2020 | 33138123 | PubTator, text mining | PubMed |
| Chronological Review and Rational and Future Prospects of Cannabis-Based Drug Development. | Molecules | 2020 | 33092255 | PubTator, text mining | PubMed |
| Evidence for adverse effects of cannabidiol (CBD) products and their non-conformity on the European food market - response to the European Industrial Hemp Association. | F1000Res | 2020 | 33082934 | PubTator, text mining | PubMed |
| Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions. | Pharmacol Res | 2020 | 33059010 | PubTator, text mining | PubMed |
| In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters. | Molecules | 2020 | 33050066 | PubTator, text mining | PubMed |
| In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes. | Drug Metab Dispos | 2020 | 33020067 | PubTator, text mining | PubMed |
| Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity. | Mol Pharmacol | 2020 | 33008919 | PubTator, text mining | PubMed |
| An In Vitro Study for Evaluating Permeability and Metabolism of Kurarinone. | Evid Based Complement Alternat Med | 2020 | 33005200 | PubTator, text mining | PubMed |
| Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists. | Ther Clin Risk Manag | 2020 | 32982255 | PubTator, text mining | PubMed |
| Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models. | Biomedicines | 2020 | 32977664 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug. | Front Pharmacol | 2020 | 32973538 | PubTator, text mining | PubMed |
| Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human. | Mol Pharm | 2020 | 32955894 | PubTator, text mining | PubMed |
| Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir. | Med Clin (Engl Ed) | 2020 | 32953990 | PubTator, text mining | PubMed |
| Identification of hub genes in diabetic kidney disease via multiple-microarray analysis. | Ann Transl Med | 2020 | 32953797 | PubTator, text mining | PubMed |
| Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker. | Cancer Chemother Pharmacol | 2020 | 32948918 | PubTator, text mining | PubMed |
| Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31: cDNA cloning, expression and initial characterization of morphine metabolism. | Vet Anaesth Analg | 2020 | 32933848 | PubTator, text mining | PubMed |
| In Vitro Metabolism of DWP16001, a Novel Sodium-Glucose Cotransporter 2 Inhibitor, in Human and Animal Hepatocytes. | Pharmaceutics | 2020 | 32932946 | PubTator, text mining | PubMed |
| Evaluation of the Pharmacokinetic Drug-Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers. | Pharmaceutics | 2020 | 32932576 | PubTator, text mining | PubMed |
| Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097. | J Acquir Immune Defic Syndr | 2020 | 32925360 | PubTator, text mining | PubMed |
| Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs. | Epilepsia | 2020 | 32918835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=38